LBA3_PRAlpelisib (ALP) + fulvestrant (FUL) for advanced breast cancer (ABC): Results of the phase III SOLAR-1 trial. (23rd October 2018) - André, F; Ciruelos, E M; Rubovszky, G; Campone, M; Loibl, S; Rugo, H S; Iwata, H; Conte, P; Mayer, I A; Kaufman, B; Yamashita, T; Lu, Y -S; et al.